Long-term risk of recurrence after surgery for kidney cancer

A recent study published in the journal European Urology investigated the long-term risk of recurrence in people who had had a nephrectomy for the treatment of localised renal cell carcinoma (RCC) in order to determine the usefulness of long-term follow-up (surveillance). A retrospective analysis of 1943 patients who took part in the ECOG E2805 clinical […]

read more

Universal active surveillance for small renal masses

A study presented at the Society of Urologic Oncology (SUO) in Washington, USA last week concluded that universal initial active surveillance for patients with small renal masses (SRMs) less than 3 cm in diameter using predefined progression criteria can safely delay or avoid treatment for most patients. In the study, active surveillance was recommended for […]

read more

IKCS 2019: Management of small renal masses

In this video interview, Dr Eric Singer from Rutgers Cancer Institute of New Jersey, USA discusses the management of small renal masses at the International Kidney Cancer Symposium (IKCS) in Miami earlier this month. Watch the video interview on Oncology Tube here

read more

Treatment of favourable-risk metastatic kidney cancer

The treatment of patients with intermediate- and poor-risk metastatic renal cell carcinoma (RCC) has been dramatically changed with the introduction of immune checkpoint inhibitors (immunotherapy) as a first-line of treatment after surgery. However, it is less clear whether immunotherapy benefits patients with favourable-risk disease in the same way. A debate between experts at the International […]

read more

Extended duration of active surveillance of small renal masses

A recent study published in the Journal of Urology evaluated the outcomes of 103 patients with small renal masses (<6 cm) who were on active surveillance. The patients were followed for a median of 55.5 months, and in that time only 1% died of metastatic renal cell carcinoma (RCC). Of the 103 patients, 51.5% survived […]

read more

Long-term surveillance of small renal masses is safe

In a recent study published in Journal of Urology and involving over 100 mostly older patients, almost all of the patients with small kidney tumours never developed advanced cancer or died of the disease during more than 4 years of follow-up in active surveillance. More than half of the patients remained alive without metastatic disease […]

read more

ASCO 2019: Active surveillance in metastatic kidney cancer

This study used data from the Canadian Kidney Cancer Information System and was presented at the American Society of Clinical Oncology (ASCO) 2019 annual meeting in Chicago earlier this week. During the study, patient outcomes and safety data were collected from patients who underwent active surveillance and compared to those who received immediate systemic treatment. […]

read more

Active surveillance of small renal masses

This study, involving 450 people, provides evidence in favour of active surveillance for small renal masses. The researchers looked at the outcomes of patients with kidney masses who chose active surveillance rather than immediate surgery. The study found that patients who need surgery are often identified early and those who remain on active surveillance become […]

read more
Showing 1 to 10 of 11 results
  TOP